Clinical Trials
4
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)(HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds
Not Applicable
Recruiting
- Conditions
- Arterial Bleeding in Solid Organs and Peripheral Arteries
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Instylla, Inc.
- Target Recruit Count
- 118
- Registration Number
- NCT05364502
- Locations
- 🇺🇸
Banner Health, Phoenix, Arizona, United States
🇺🇸Memorial Health Services, Long Beach, California, United States
🇺🇸Stanford University, Stanford, California, United States
Instylla HES Hypervascular Tumor Pivotal Study
Not Applicable
Completed
- Conditions
- Hypervascular Tumors
- First Posted Date
- 2020-08-21
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Instylla, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT04523350
- Locations
- 🇺🇸
UAB Hospital, Birmingham, Alabama, United States
🇺🇸Central Arkansas Radiation Therapy Institute, Inc., Little Rock, Arkansas, United States
🇺🇸University of California, Irvine, Irvine, California, United States
News
No news found